X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GRTX

Closed

Galera Therapeutics Inc

0.026
-0.001 (-3.68%)
Last Update: 01 Jul 2025 22:45:00
Yesterday: 0.0272
Day's Range: 0.026 - 0.026
Send
When Written:
 
2.5299
Galera Therapeutics Inc is a clinical-stage biotechnology company that is focused on developing and commercializing innovative therapeutics for the treatment of cancer and other diseases. The company's lead product candidate is GC4419, a highly selective and potent small molecule that is designed to protect normal tissue from the harmful effects of radiation therapy. GC4419 is currently being evaluated in a Phase 3 clinical trial for the prevention of severe oral mucositis in patients undergoing radiation therapy for head and neck cancer. Galera Therapeutics was founded in 2010 and is headquartered in Malvern, Pennsylvania. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol "GRTX".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X